Location: United States, California, San Clemente
Employees: 11-50
Total raised: $46M
Founded date: 2004
Investors 1
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.09.2016 | - | $40M | - |
| 07.09.2012 | - | $6M | - |
Mentions in press and media 7
| Date | Title | Description |
| 06.09.2016 | ROX Medical Receives $40M | SAN CLEMENTE, CA, ROX Medical, a privately held clinical-stage medical device company developing technologies for hypertension, announced today that it has secured $40M in Series E financing. >> Click here for more funding data on ... |
| 06.09.2016 | ROX Medical Raises $40M in Funding | ROX Medical, a San Clemente, CA-based clinical-stage medical device company developing technologies for hypertension, secured $40M in Series E financing. The round was led by Novartis Venture Fund and Apple Tree Partners with participation ... |
| 06.09.2016 | ROX Medical Raises $40M Financing | |
| 06.09.2016 | ROX Medical Gets $40M Funding | San Clemente-based ROX Medical, a startup developing medical devices to treat hypertension, has raised $40M in a Series E funding, the company said this morning. The funding was led by Novartis Venture Fund and Apple Tree Partners and also ... |
| 07.09.2012 | ROX Medical Closes $6M Financing Round | ROX Medical, a San Clemente, Calif.-based early phase medical device company that is pioneering an innovative treatment for Chronic Obstructive Pulmonary Disease (COPD), has closed a $6m financing round. Backers include existing investors D... |
| 07.09.2012 | ROX Medical Closes $6M | SAN CLEMENTE, CA, ROX Medical announced the closing of a financing round totaling $6M. The financing will be used to initiate an international trial of the ROX FLOW procedure for the treatment of resistant hypertension. >> Click he... |
| 20.12.2010 | Endologix Appoints Guido Neels to Its Board of Directors | Dec 20 2010 IRVINE, California—Endologix, Inc. (NASDAQ: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Guido Neels, Managing Director at Essex Woodlands Health Ventures, has joined the Endologi... |